Exosome-Displayed Fusion Proteins Unlock TNF Receptor Superfamily Agonism for Cancer Immunotherapy
Time: 3:30 pm
day: Conference Day Two
Details:
- Overcoming the challenge of TNFRSF agonism: limitations of traditional protein biologics
- Engineering multivalent exosome display using a novel type II transmembrane anchor
- Demonstrating superior agonist activity: In vitro and in vivo validation
NEW COMPANY!